This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
Should You Buy 89BIO (ETNB) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ETNBPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
PGENPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Lionsgate Studios Corp. (LION)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
LIONPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Pick These 4 Stocks With Solid Net Profit Margin to Boost Return
by Anirudha Bhagat
Let's take a look at four stocks, GFF, BGC, CHX and CDXC, with impressive net profit margins for a robust portfolio.
BGCPositive Net Change GFFPositive Net Change
fin-tech tech-stocks
Should You Buy, Sell or Hold Sea Limited Stock at P/S of 3.68X?
by Nilanshi Mukherjee
SE stock benefits from Shopee and Garena's growth, but its high valuation and rising competition suggest investors should wait for a favorable entry point.
SEPositive Net Change WDAYNegative Net Change HUBSPositive Net Change NCNONegative Net Change
artificial-intelligence e-commerce fin-tech tech-stocks
Should You Buy Portillo's Inc. (PTLO) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PTLONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CBRE to Report Q4 Earnings: Key Factors to Consider for the Stock
by Zacks Equity Research
A focus on resilient business and diversification across property types, lines of business, geographic markets and clients is likely to aid CBRE's Q4 results.
JLLPositive Net Change CBREPositive Net Change CWKPositive Net Change
earnings fin-tech reit
BILL Plunges 36% Post Q2 Earnings: Is the Stock Worth Buying on the Dip?
by Nilanshi Mukherjee
BILL benefits from strong revenue growth, expanding its customer base, and innovative AI-driven automation, positioning the company for sustained success.
RFNegative Net Change INTUPositive Net Change BILLNegative Net Change ADYEYPositive Net Change
artificial-intelligence fin-tech tech-stocks
5 Must-Buy U.S. Financial Technology Behemoths for the Long Term
by Nalak Das
Here, we present financial technology stocks that have strong revenue and earnings growth potential for 2025. These are V, PYPL, AXP, AFRM and FIS.
VPositive Net Change AXPPositive Net Change FISPositive Net Change PYPLPositive Net Change AFRMNegative Net Change
fin-tech
3 Relative Strength Stocks to Buy Now: IREN, SERV, FUTU
by Andrew Rocco
While amateur investors often tune out during red markets, savvy investors understand the power of searching for relative strength and stocks bucking the market weakness. IREN, SERV, & FUTU are three such stocks.
MSFTPositive Net Change GOOGLPositive Net Change SERVPositive Net Change SHAKPositive Net Change UBERPositive Net Change FUTUPositive Net Change IRENNegative Net Change
bitcoin fin-tech investing
TAL Education (TAL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TALPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
World Acceptance (WRLD) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
WRLDPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Blueprint Medicines (BPMC) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Upstart Gears Up to Report Q4 Earnings: Buy, Sell or Hold the Stock?
by Anirudha Bhagat
Recent rate cuts by the Federal Reserve, innovative product launches and an AI-driven consumer lending model are likely to have boosted UPST's Q4 revenues.
XLFPositive Net Change LCPositive Net Change UPSTPositive Net Change SOFIPositive Net Change
artificial-intelligence earnings-estimates-revisions earnings-preview earnings-report earnings-surprise fin-tech
Should You Buy Pacira (PCRX) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
PCRXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
JKHY Q2 Earnings Beat: Will 2025 Outlook Drag the Stock Down?
by Zacks Equity Research
Jack Henry & Associates' second-quarter fiscal 2025 results reflect modest growth across its Core, Payments, Complementary and Corporate & Other segments.
CLSNegative Net Change JKHYPositive Net Change CRWDPositive Net Change BILLNegative Net Change
fin-tech finance tech-stocks
3 Stocks Thriving Despite Tariffs Concerns
by Ethan Feller
While ongoing tariff news shakes the market Meta Platforms, Amazon and Interactive Brokers shares continue to rally
AMZNPositive Net Change IBKRPositive Net Change METANegative Net Change
artificial-intelligence fin-tech tech-stocks
Bull of the Day: Sea Limited (SE)
by Ethan Feller
Sea Limited stock continues to gain momentum as earnings forecasts rise
SEPositive Net Change
e-commerce fin-tech gaming tech-stocks
Bull of the Day: Virtu Financial (VIRT)
by David Bartosiak
All-time highs for this HFT firm have come with increased earnings as well.
VIRTNegative Net Change
fin-tech
Upstart Holdings Stock Soars 36% in 3 Months: Time to Hold or Fold?
by Anirudha Bhagat
UPST's 36% surge highlights strong AI-driven growth, but its high valuation suggests holding the stock is the best move for now.
XLFPositive Net Change LCPositive Net Change UPSTPositive Net Change SOFIPositive Net Change
artificial-intelligence computers fin-tech tech-stocks
SoFi Technologies Stock Gains 121% in 6 Months: Buy, Hold, or Sell?
by Shuvra Shankar Dey
Given the continuous surge in SOFI shares, we evaluate the stock's current position to determine how to play it now.
BACPositive Net Change WFCPositive Net Change JPMPositive Net Change SOFIPositive Net Change
fin-tech finance
Visa & Elon Musk's X: A Power Play in the Race for Fintech Dominance?
by Kaibalya Pravo Dey
As X Money integrates with Visa Direct, millions of X users could start using Visa's network, driving up transaction volume and fees.
MAPositive Net Change VPositive Net Change TSLAPositive Net Change PYPLPositive Net Change
business-services creator-economy fin-tech finance payments social-media
Grupo Aeroportuario del Centro Norte (OMAB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
OMABPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
UiPath (PATH) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PATHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Ease-of-Use AI Platform DeepSeek Send U.S. Pre-Markets Reeling
by Mark Vickery
We're looking at a big drop in pre-market equities to start the last week on the first month of 2025.
NVDAPositive Net Change SOFIPositive Net Change
artificial-intelligence earnings fin-tech